Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aprea Therapeutics Inc
APRECurrent price
3.85 USD
+0.089 USD (+2.36%)
Last closed
3.75 USD
Company
www.aprea.com
ISIN
US03836J1025
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
17 717 774 USD
Yield for 12 month
-33.87 %
1Y
3Y
5Y
10Y
15Y
APRE
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. Address: 3805 Old Easton Road, Doylestown, PA, United States, 18902
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.67 USDP/E ratio
–Dividend Yield
–Current Year
+583 231 USD
Last Year
–
Current Quarter
–
Last Quarter
+561 574 USD
Current Year
+576 179 USD
Last Year
-186 445 USD
Current Quarter
–
Last Quarter
+556 269 USD
Key Figures APRE
1 year
3 years
5 years
10 years
EBITDA
-14 176 494 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-30.26 %
PEG Ratio
–
Return On Equity TTM
-50.11 %
Wall Street Target Price
15.67 USD
Revenue TTM
1 275 686 USD
Book Value
4.54 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
124.90 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.80 USD
Diluted Eps TTM
-2.80 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics APRE
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History APRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
13.02.2023
Dividend Date
–
Stock Valuation APRE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
13.89
Enterprise Value EBITDA
0.35
Price Book MRQ
0.81
Financials APRE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators APRE
For 52 weeks
2.15 USD
8.85 USD
50 Day MA
3.41 USD
Shares Short Prior Month
9 511
200 Day MA
4.32 USD
Short Ratio
0.55
Shares Short
10 983
Short Percent
0.38 %
BeatStart